Overview

Treatment of Chronic Mountain Sickness

Status:
Recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
This study aims to assess the effect of two drugs for the treatment of chronic mountain sickness in highlanders.
Phase:
N/A
Details
Lead Sponsor:
Centre d'Expertise sur l'Altitude EXALT
Centre d’Expertise sur l’Altitude EXALT
Treatments:
Acetazolamide
Atorvastatin